Advanced Enzyme Technologies Limited
Advanced Enzyme Technologies Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: ADVENZYMES and BSE: 540025 (ISIN INE837H01020).
It has a market capitalisation of ₹2,932 crore, a last close of ₹262.00 on 2026-10-19, a one-year return of -16.3%.
Valuation: a price-to-earnings ratio of 17.68x, a price-to-book ratio of 1.80x, a dividend yield of 0.5%.
Profitability: return on equity of 11.1%, return on capital employed of 14.4%, an operating margin of 29.8%.
Growth: sales growth of 11.3% a year over three years, net profit growth of 16.9% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.01x, promoter holding of 43.6%.
| Metric | Value |
|---|---|
| Market capitalisation | 2,932 |
| Last close | ₹262.00 |
| P/E (TTM) | 17.68x |
| P/B | 1.80x |
| Dividend yield | 0.5% |
| ROE (FY) | 11.1% |
| ROCE (FY) | 14.4% |
| Operating margin (TTM) | 29.8% |
| Sales growth, 3-year CAGR | 11.3% |
| Profit growth, 3-year CAGR | 16.9% |
| Debt / equity | 0.01x |
| Promoter holding | 43.6% |
| 1-year return | -16.3% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means